Muhammad Wasif Saif, Saravanan Kokila Krishnamoorthy, Sachin Jambawaliker
Positron emission tomography (PET) using 18F-fluorodeoxyglucose (FDG) is increasingly used for the staging of solidmalignancies, including lung and esophagus. However, controversy still exists in relation to the application of PET inpancreatic cancer. The authors review seven studies (Abstracts #183, #189, #190, #254, #357, #375, #378) presented at the2014 ASCO Gastrointestinal Cancers Symposium and discuss on the role of PET in this disease. As the limitations of theResponse Evaluation Criteria In Solid Tumors (RECIST) continue to become evident, FDG-PET may identify changes in themetabolic activity within pancreatic adenocarcinoma, and can provide both diagnostic and prognostic information.
